Table 2 Univariate analysis for prognostic parameters in pancreatic cancer for median overall survival (OAS) and median recurrence-free (RFS).
Characteristics | RFS* | OAS | ||||
|---|---|---|---|---|---|---|
No. of Cases | Time (months) | P-Value | No. Of cases | Time (months) | P-Value | |
Adjuvant Chemotherapy† | ||||||
Not received | 14 | 7 | 0.6 | 18 | 4.5 | 0.0001 |
Received | 65 | 15 | 69 | 22.8 | ||
Lymph node status | ||||||
N0 | 16 | 24 | 0.34 | 18 | 32.2 | 0.04 |
N1 | 64 | 12 | 78 | 17.7 | ||
AJCC tumour stage | ||||||
2 | 16 | 24 | 0.28 | 18 | 32.2 | 0.001 |
3 | 59 | 12 | 73 | 18.7 | ||
4 | 5 | 6 | 5 | 10.9 | ||
ALDH1A1 | ||||||
Low | 47 | 11 | 0.029 | 58 | 16.3 | 0.012 |
High | 33 | 17 | 38 | 32.3 | ||